EUR/USD so far manages to keep the trade in the upper bound of the daily range, testing 1.0850 ahead of key German data.
EUR/USD up on ‘Trumpcare’
Spot opened Monday’s session with an important gap to the area near 1.0850, fresh yearly tops, after the House of Republicans voted against the American Health Care Act, known as ‘Trumpcare’ last Friday.
The vote poured cold water over the future implementation of further fiscal measures from the new US administration, triggering a significant risk-off sentiment across the markets.
The US Dollar Index has plummeted after the opening bell in Asia today, dragging the buck to the 99.00 neighbourhood, levels last traded in early November.
Adding extra support to EUR, speculative net shorts have been trimmed to levels last seen in June 2014 during the week ended on March 21 according to the latest CFTC report.
On the data front, the German IFO is due along with the speech by ECB’s P.Praet, while Chicago Fed C.Evans (voter, dovish) is due to speak later in the NA session.
EUR/USD levels to watch
At the moment the pair is up 0.44% at 1.0846 facing the immediate hurdle at 1.0873 (high Dec.8 2016) followed by 1.0882 (200-day sma) and finally 1.1300 (high Nov.9 2016). On the flip side, a breakdown of 1.0838 (low Mar.27) would target 1.0759 (low Mar.24) en route to 1.0704 (low Mar.16).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.